Previously, Kossel Medtech (Suzhou) Co., Ltd. (hereinafter referred to as “Kossel Medtech”) completed the strategic acquisition of the peripheral vascular intervention business of Shanghai Biotriton Medical Technology Co., Ltd (hereinafter referred to as “Biotriton Medical”), further strengthening Kossel Medtech’s comprehensive one-stop diagnosis and treatment portfolio in the peripheral intervention field.
Recently, Biotriton Medical’s independently developed K-VisionMax™ Peripheral IVUS System, including the Peripheral Intravascular Ultrasound Diagnostic Catheter (Registration No.: GXZZ 20263061165) and the Intravascular Ultrasound Diagnostic System (Registration No.: GXZZ 20263061218), has successfully received market approval from the National Medical Products Administration (NMPA).
K-VisionMax™ Peripheral IVUS System
Four Key Advantages
30 MHz High-Definition Imaging
Equipped with a 30 MHz mechanically rotating transducer, delivering clearer images and richer anatomical details.
40 mm Ultra-Wide Imaging Range
Featuring an extra-large 40 mm imaging diameter, enabling comprehensive visualization of both arteries and veins while meeting the demands of complex clinical cases.
0.018″ Rapid-Exchange Design
Compatible with standard 0.018″ guidewires and 6F introducer sheaths, allowing for easier operation and minimizing procedural trauma.
Comprehensive Clinical Application
Designed to support a full spectrum of peripheral vascular interventions, including the carotid arteries, lower-extremity arteries and veins, iliac veins, and other peripheral vascular applications.
As an important milestone in China’s peripheral vascular intervention sector, the K-VisionMax™ Peripheral IVUS System integrates high-definition imaging, procedural convenience, and broad clinical applicability into a single platform. It provides clinicians with a cost-effective and precise intravascular imaging solution, ushering in a new era of precision diagnosis and treatment in peripheral vascular intervention and benefiting more patients.